Neulasta Delivery Kit Provides New Option for Patients Amgen announced the launch of Neulasta (pegfilgrastim) Delivery Kit that allows the healthcare provider to initiate Neulasta on the same day as ...
Neulasta (pegfilgrastim) is a brand-name drug that’s prescribed to treat radiation sickness and prevent certain complications of chemotherapy. Neulasta comes as an injectable solution. The dosage can ...
In 2015, the Neulasta On-Body Injector (OBI) Onpro device was introduced as a less costly method of pegfilgrastim administration. While the device has been found to be safe in healthy volunteers and ...
Neulasta Delivery Kit Provides Administration Option for Patients who may not Otherwise Need to Return to Clinic or Hospital the day After Chemotherapy One of the most common side effects of ...
Credit: Coherus. The on-body injector includes features such as a retractable needle mechanism, an indicator, status light and auditory signal to help patients confirm the dose has been administered.
Amgen announced that the Neulasta (pegfilgrastim) Delivery Kit is now available in the United States (US). The Neulasta Delivery Kit includes a specially designed single-use prefilled syringe ...
Amgen ads talking up its Neulasta on-body injection system caught the FDA’s attention—with the help of some “Bad Ad” tattlers. The FDA slapped Amgen with an untitled letter last week for banner ad ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Chemotherapy is a brutal but often life-saving treatment for an even worse disease. It can also reduce a patient’s white blood cell count, which hinders the body’s ability to fight off infections.
Novartis’ Sandoz unit has filed for approval of its fifth biosimilar in Europe, this time taking aim at the market for Amgen’s Neulasta. The European Medicines Agency (EMA) has now started its review ...
Expect the unexpected—such is my life with cancer. My white cell count was too low, below one, so the doctor could not administer my chemotherapy treatment last week. The issue could have been ...